Silibinin mode of action against hepatitis C virus: a controversy yet to be resolved
Hepatology
.
2011 Aug;54(2):749.
doi: 10.1002/hep.24310.
Epub 2011 Jun 27.
Authors
Harel Dahari
,
Jeremie Guedj
,
Alan S Perelson
PMID:
21433039
PMCID:
PMC3677944
DOI:
10.1002/hep.24310
No abstract available
Publication types
Letter
Comment
MeSH terms
Hepacivirus / drug effects*
Humans
Silybin
Silymarin / pharmacology*
Substances
Silymarin
Silybin
Grants and funding
R56 AI065256/AI/NIAID NIH HHS/United States
R37 AI028433/AI/NIAID NIH HHS/United States
R01 AI028433/AI/NIAID NIH HHS/United States
R01 RR006555/RR/NCRR NIH HHS/United States
R01 AI078881/AI/NIAID NIH HHS/United States
R01 AI065256/AI/NIAID NIH HHS/United States
R01 OD011095/OD/NIH HHS/United States